New RF Generator Increases Ablation Efficiency
|
By HospiMedica International staff writers Posted on 26 Jul 2017 |

Image: The MultiGen 2 RF Generator provides double the power of other systems (Photo courtesy of Stryker).
An innovative radio frequency (RF) generator with double the industry standard for power achieves target temperature faster and with fewer errors.
The Stryker Corporation (Kalamazoo, MI, USA) MultiGen 2 RF Generator is a bipolar and monopolar, high frequency electrosurgical system designed to deliver 100 watts of temperature-controlled RF energy, allowing users to ramp up to temperature faster. The system is intended for RF coagulation, selective denervation, and soft tissue destruction in orthopedic, spinal, and neurosurgical applications of the lumbar, thoracic, and cervical regions, including treatment of facet denervation, trigeminus neuralgia, peripheral neuralgias, and rhizotomy.
RF procedures can be started with a single touch of a button, creating a strip lesion without removing electrodes, and resolve ablation errors without stopping the procedure. Flexible stimulation controls allow surgeons to choose the order of lesions with independently run channels. Additional features include an ultra-responsive touch screen, a USB port for saving and transferring presets, and a lifecycle tracker for electrode use. The MultiGen 2 RF Generator is used together with the MultiGen 2 Splitter Cable and the Venom cannula and electrode system, all part of the Stryker Performance Platform.
“The next generation of radiofrequency ablation has arrived,” said Brad Wallace, brand manager for Stryker. “The MultiGen 2 RF Generator provides physicians with control and confidence, making radiofrequency ablation more efficient and reliable than ever before.”
RF ablation is sometimes used to treat severe chronic pain in the lumbar region, on specifically identified nerves surrounding the facet joints on either side of the spine. By generating heat around the nerve, the nerve is ablated, destroying its ability to transmit signals to the brain. The minimally invasive procedure, also known as rhizotomy, can usually be done in day-surgery clinics. A drawback of the procedure is that the nerves recover function over time, so the pain relief achieved lasts for only a short duration (3-15 months) in most patients.
Related Links:
Stryker Corporation
The Stryker Corporation (Kalamazoo, MI, USA) MultiGen 2 RF Generator is a bipolar and monopolar, high frequency electrosurgical system designed to deliver 100 watts of temperature-controlled RF energy, allowing users to ramp up to temperature faster. The system is intended for RF coagulation, selective denervation, and soft tissue destruction in orthopedic, spinal, and neurosurgical applications of the lumbar, thoracic, and cervical regions, including treatment of facet denervation, trigeminus neuralgia, peripheral neuralgias, and rhizotomy.
RF procedures can be started with a single touch of a button, creating a strip lesion without removing electrodes, and resolve ablation errors without stopping the procedure. Flexible stimulation controls allow surgeons to choose the order of lesions with independently run channels. Additional features include an ultra-responsive touch screen, a USB port for saving and transferring presets, and a lifecycle tracker for electrode use. The MultiGen 2 RF Generator is used together with the MultiGen 2 Splitter Cable and the Venom cannula and electrode system, all part of the Stryker Performance Platform.
“The next generation of radiofrequency ablation has arrived,” said Brad Wallace, brand manager for Stryker. “The MultiGen 2 RF Generator provides physicians with control and confidence, making radiofrequency ablation more efficient and reliable than ever before.”
RF ablation is sometimes used to treat severe chronic pain in the lumbar region, on specifically identified nerves surrounding the facet joints on either side of the spine. By generating heat around the nerve, the nerve is ablated, destroying its ability to transmit signals to the brain. The minimally invasive procedure, also known as rhizotomy, can usually be done in day-surgery clinics. A drawback of the procedure is that the nerves recover function over time, so the pain relief achieved lasts for only a short duration (3-15 months) in most patients.
Related Links:
Stryker Corporation
Latest Surgical Techniques News
- Ultrasound Technology Aims to Replace Invasive BPH Procedures
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
- Fluorescence Probe Paired with Engineered Enzymes Lights Up Tumors for Easier Surgical Removal
- Novel Hydrogel Could Become Bone Implant of the Future
Channels
Artificial Intelligence
view channelAI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read moreCritical Care
view channel
Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
Hospitalizations for heart failure with preserved ejection fraction (HFpEF) remain common because lung congestion often worsens before symptoms prompt treatment changes. Missed early decompensation... Read more
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







